Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)'s assets in the Indianapolis and Costa Rica divisions.
 
CRI is a manufacturer of interventional catheters, tube sets, and other assemblies for medical devices with expertise in tube extrusion, catheter assembly and final FDA product packaging for sterilization. CRI services OEM customers as well as sell their own catheter line under the brand Thomas Medical.
 
"Through the addition of CRI, we are in a position to serve the medical device industry at an even higher level," stated Brad Brown, CEO at ATL. "This expansion of our global network offers numerous benefits to both national and international OEMs. Now, combining ATLs connector know-how with CRI's catheter capabilities, we will make optimal use of our expertise and specialties relating to catheters and custom engineering in delivering a best-in-class product."
 
"This acquisition is consistent with Biomerics' overall strategy to expand and invest in additional production and engineering capabilities to develop a global competitive advantage," said Travis Sessions, CEO, Biomerics. "CRI's products and technology complement our current portfolio in the medical space and will broaden our product offering for suppliers around the world."
 
CRI has manufacturing both domestically (Indianapolis, Ind.) and internationally (Costa Rica). The employees at these locations will be working closely with teams from ATL and Biomerics throughout the integration process and as they work to expand the Costa Rica operation.